Morisaki T, Morisaki T, Kubo M, Morisaki S, Nakamura Y, Onishi H
Cancers (Basel). 2022; 14(10).
PMID: 35626042
PMC: 9140043.
DOI: 10.3390/cancers14102438.
Bae S, Youk J, Yoon C, Park S, Cha C, Lee H
Eur Radiol. 2019; 30(2):789-797.
PMID: 31696293
PMC: 6957551.
DOI: 10.1007/s00330-019-06473-5.
Ginter P, Karagiannis G, Entenberg D, Lin Y, Condeelis J, Jones J
Cancers (Basel). 2019; 11(10).
PMID: 31597373
PMC: 6827388.
DOI: 10.3390/cancers11101507.
Naxerova K, Reiter J, Brachtel E, Lennerz J, van de Wetering M, Rowan A
Science. 2017; 357(6346):55-60.
PMID: 28684519
PMC: 5536201.
DOI: 10.1126/science.aai8515.
Fidalgo F, Rodrigues T, Pinilla M, Silva A, Maciel M, Rosenberg C
Tumour Biol. 2014; 36(3):1835-48.
PMID: 25391423
PMC: 4375298.
DOI: 10.1007/s13277-014-2786-z.
Detection methods predict differences in biology and survival in breast cancer patients.
Redondo M, Funez R, Medina-Cano F, Rodrigo I, Acebal M, Tellez T
BMC Cancer. 2012; 12:604.
PMID: 23244222
PMC: 3541058.
DOI: 10.1186/1471-2407-12-604.
Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231.
Aguilar-Rojas A, Huerta-Reyes M, Maya-Nunez G, Arechavaleta-Velasco F, Conn P, Ulloa-Aguirre A
BMC Cancer. 2012; 12:550.
PMID: 23176180
PMC: 3518142.
DOI: 10.1186/1471-2407-12-550.
Changes in specialized blood vessels in lymph nodes and their role in cancer metastasis.
Lee S, Chao-Nan Q, Seng O, Peiyi C, Bernice W, Swe M
J Transl Med. 2012; 10:206.
PMID: 23035663
PMC: 3551724.
DOI: 10.1186/1479-5876-10-206.
Analysis of a novel highly metastatic melanoma cell line identifies osteopontin as a new lymphangiogenic factor.
Liersch R, Shin J, Bayer M, Schwoppe C, Schliemann C, Berdel W
Int J Oncol. 2012; 41(4):1455-63.
PMID: 22797548
PMC: 3583651.
DOI: 10.3892/ijo.2012.1548.
Exploring molecular links between lymph node invasion and cancer prognosis in human breast cancer.
Kim S, Nam H, Lee D
BMC Syst Biol. 2012; 5 Suppl 2:S4.
PMID: 22784575
PMC: 3287484.
DOI: 10.1186/1752-0509-5-S2-S4.
Hormone receptor status in breast cancer and its relation to age and other prognostic factors.
Pourzand A, Fakhree M, Hashemzadeh S, Halimi M, Daryani A
Breast Cancer (Auckl). 2011; 5:87-92.
PMID: 21695095
PMC: 3117624.
DOI: 10.4137/BCBCR.S7199.
HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy.
Fukuoka H, Cooper O, Mizutani J, Tong Y, Ren S, Bannykh S
Mol Endocrinol. 2010; 25(1):92-103.
PMID: 21106881
PMC: 3089034.
DOI: 10.1210/me.2010-0353.
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family.
Shepard H, Brdlik C, Schreiber H
J Clin Invest. 2008; 118(11):3574-81.
PMID: 18982164
PMC: 2575712.
DOI: 10.1172/JCI36049.
Genomic signatures of breast cancer metastasis.
Urquidi V, Goodison S
Cytogenet Genome Res. 2007; 118(2-4):116-29.
PMID: 18000362
PMC: 2546496.
DOI: 10.1159/000108292.
ErbB receptors: from oncogenes to targeted cancer therapies.
Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R
J Clin Invest. 2007; 117(8):2051-8.
PMID: 17671639
PMC: 1934579.
DOI: 10.1172/JCI32278.
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
Allan A, George R, Vantyghem S, Lee M, Hodgson N, Engel C
Am J Pathol. 2006; 169(1):233-46.
PMID: 16816376
PMC: 1698777.
DOI: 10.2353/ajpath.2006.051152.
No common denominator for breast cancer lymph node metastasis.
Weigelt B, Wessels L, Bosma A, Glas A, Nuyten D, He Y
Br J Cancer. 2005; 93(8):924-32.
PMID: 16189523
PMC: 2361648.
DOI: 10.1038/sj.bjc.6602794.
A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes.
Vantyghem S, Allan A, Postenka C, Al-Katib W, Keeney M, Tuck A
Clin Exp Metastasis. 2005; 22(4):351-61.
PMID: 16170671
DOI: 10.1007/s10585-005-0745-1.
[Molecular biology approach to explain lymphatic metastasis].
Dorp F, Wullich B, Gulbins E, Eisenhardt A
Urologe A. 2005; 44(6):608-13.
PMID: 15912324
DOI: 10.1007/s00120-005-0833-5.
Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes.
Pittman J, Huang E, Dressman H, Horng C, Cheng S, Tsou M
Proc Natl Acad Sci U S A. 2004; 101(22):8431-6.
PMID: 15152076
PMC: 420411.
DOI: 10.1073/pnas.0401736101.